Literature DB >> 15746432

Lysozyme secretion by submucosal glands protects the airway from bacterial infection.

Rana Dajani1, Yulong Zhang, Peter J Taft, Sue M Travis, Timothy D Starner, Ansgar Olsen, Joseph Zabner, Michael J Welsh, John F Engelhardt.   

Abstract

Submucosal glands are abundant (approximately 1 gland/mm2) secretory structures in the tracheobronchial airways of the human lung. Because submucosal glands express antibacterial proteins, it has been proposed that they contribute to lung defense. However, this concept is challenged by the fact that mice do not have submucosal glands in their bronchial airways, yet are quite resistant to bacterial lung infection. The contribution of airway submucosal glands to host defense is also debated as a pathophysiologic component of cystic fibrosis lung disease. Here, we asked whether submucosal glands protect airways against bacterial infection. By comparing tracheal xenograft airways with and without glands, we found that the presence of glands enhanced bacterial killing in vivo and by airway secretions in vitro. Moreover, immunodepletion studies suggested that lysozyme is a major antibacterial component secreted by submucosal glands. These studies provide evidence that submucosal glands are a major source of antibacterials critical for maintaining sterile airways.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15746432      PMCID: PMC2715323          DOI: 10.1165/rcmb.2005-0059OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  21 in total

1.  New models of the tracheal airway define the glandular contribution to airway surface fluid and electrolyte composition.

Authors:  X Wang; Y Zhang; A Amberson; J F Engelhardt
Journal:  Am J Respir Cell Mol Biol       Date:  2001-02       Impact factor: 6.914

2.  A component of innate immunity prevents bacterial biofilm development.

Authors:  Pradeep K Singh; Matthew R Parsek; E Peter Greenberg; Michael J Welsh
Journal:  Nature       Date:  2002-05-30       Impact factor: 49.962

3.  Activity of abundant antimicrobials of the human airway.

Authors:  S M Travis; B A Conway; J Zabner; J J Smith; N N Anderson; P K Singh; E P Greenberg; M J Welsh
Journal:  Am J Respir Cell Mol Biol       Date:  1999-05       Impact factor: 6.914

4.  Secretion of lactoferrin and lysozyme by cultures of human airway epithelium.

Authors:  R F Dubin; S K Robinson; J H Widdicombe
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-04       Impact factor: 5.464

Review 5.  Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease.

Authors:  A S Verkman; Yuanlin Song; Jay R Thiagarajah
Journal:  Am J Physiol Cell Physiol       Date:  2003-01       Impact factor: 4.249

6.  Cationic polypeptides are required for antibacterial activity of human airway fluid.

Authors:  Alexander M Cole; Hsiang-I Liao; Olga Stuchlik; Jason Tilan; Jan Pohl; Tomas Ganz
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

Review 7.  Human antimicrobial peptides: analysis and application.

Authors:  A M Cole; T Ganz
Journal:  Biotechniques       Date:  2000-10       Impact factor: 1.993

8.  A comparative study of mammalian tracheal mucous glands.

Authors:  H K Choi; W E Finkbeiner; J H Widdicombe
Journal:  J Anat       Date:  2000-10       Impact factor: 2.610

9.  Submucosal gland secretions in airways from cystic fibrosis patients have normal [Na(+)] and pH but elevated viscosity.

Authors:  S Jayaraman; N S Joo; B Reitz; J J Wine; A S Verkman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

10.  Absent secretion to vasoactive intestinal peptide in cystic fibrosis airway glands.

Authors:  Nam Soo Joo; Toshiya Irokawa; Jin V Wu; Robert C Robbins; Richard I Whyte; Jeffrey J Wine
Journal:  J Biol Chem       Date:  2002-10-03       Impact factor: 5.157

View more
  53 in total

1.  The air-liquid interface and use of primary cell cultures are important to recapitulate the transcriptional profile of in vivo airway epithelia.

Authors:  Alejandro A Pezzulo; Timothy D Starner; Todd E Scheetz; Geri L Traver; Ann E Tilley; Ben-Gary Harvey; Ronald G Crystal; Paul B McCray; Joseph Zabner
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-22       Impact factor: 5.464

Review 2.  Stem cells in the lung.

Authors:  Xiaoming Liu; Ryan R Driskell; John F Engelhardt
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

3.  The lactoperoxidase system links anion transport to host defense in cystic fibrosis.

Authors:  Gregory E Conner; Corinne Wijkstrom-Frei; Scott H Randell; Vania E Fernandez; Matthias Salathe
Journal:  FEBS Lett       Date:  2006-12-19       Impact factor: 4.124

4.  Distribution of mucins and antimicrobial substances lysozyme and lactoferrin in the laryngeal subglottic region.

Authors:  Hannes Kutta; Andreas Willer; Philipp Steven; Lars Bräuer; Michael Tsokos; Friedrich Paulsen
Journal:  J Anat       Date:  2008-07-22       Impact factor: 2.610

Review 5.  The glandular stem/progenitor cell niche in airway development and repair.

Authors:  Xiaoming Liu; John F Engelhardt
Journal:  Proc Am Thorac Soc       Date:  2008-08-15

Review 6.  Innate immunity in the respiratory epithelium.

Authors:  Dane Parker; Alice Prince
Journal:  Am J Respir Cell Mol Biol       Date:  2011-02-17       Impact factor: 6.914

7.  Viral Vectors, Animal Models, and Cellular Targets for Gene Therapy of Cystic Fibrosis Lung Disease.

Authors:  Yinghua Tang; Ziying Yan; John F Engelhardt
Journal:  Hum Gene Ther       Date:  2020-04-15       Impact factor: 5.695

8.  Mucus secretion from individual submucosal glands of the ferret trachea.

Authors:  Hyung-Ju Cho; Nam Soo Joo; Jeffrey J Wine
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-04-30       Impact factor: 5.464

9.  Increased susceptibility to pulmonary Pseudomonas infection in Splunc1 knockout mice.

Authors:  Yanyan Liu; Marissa E Di; Hong Wei Chu; Xinyu Liu; Ling Wang; Sally Wenzel; Y Peter Di
Journal:  J Immunol       Date:  2013-09-18       Impact factor: 5.422

10.  In vitro and in vivo functional characterization of gutless recombinant SV40-derived CFTR vectors.

Authors:  C Mueller; M S Strayer; J Sirninger; S Braag; F Branco; J-P Louboutin; T R Flotte; D S Strayer
Journal:  Gene Ther       Date:  2009-11-05       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.